AzTrials
AzTrials

Procedural AnxietyNCT03740607

Virtual Reality for Alleviation of Peripheral IV Placement-Associated Discomfort

A study testing Virtual reality and Peripheral intravenous catheter placement in people with Procedural Anxiety and Procedural Pain, run by Brooke Army Medical Center at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Immersive virtual reality (iVR) has been used successfully to manage pain with distraction. It is a non-invasive treatment modality unassociated with worrisome well-known side effects typically seen when opioids and NSAIDS are used, and has previously been used safely in place of analgesia during dressing changes and… Read more about this study

Who is it for?
Ages 18 to 89 years
What is being tested?
Virtual reality and Peripheral intravenous catheter placement
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
1 siteUnited States
Study dates
1 Mar 2019to 15 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 89 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Brooke Army Medical Center patients age 19-89 undergoing peripheral intravenous catheter placement in preparation for elective surgery will be eligible for participation.

Who cannot join

  • Patients will be excluded with head wounds/head bandages preventing the use of a headset, active nausea/vomiting, history of seizure, dementia, psychosis, mania, vertigo, or motion sickness, if the patient is pregnant or incarcerated on the day of surgery, and if the patient is unable to consent self.

Trial locations and contacts

1 site in 1 country.

Annie L Chow, MD, MPH, MS contact

6093063329

chowanni@gmail.com

Cheng Yang, MD contact

chengyang448@gmail.com

United States1 site, 1 recruiting
  • Brooke Army Medical Center

    San Antonio, Texas, 78234

    Annie Chow, MD, 210-228-6877, annie.l.chow.mil@mail.mil

    Recruiting

Other trials in United States

About this study

Immersive virtual reality (iVR) has been used successfully to manage pain with distraction. It is a non-invasive treatment modality unassociated with worrisome well-known side effects typically seen when opioids and NSAIDS are used, and has previously been used safely in place of analgesia during dressing changes and burn care. This study investigates whether iVR can be useful as a stand-alone option to manage the pain associated with placement of peripheral intravenous (PIV) catheters in adults.

Read the detailed description

This is a prospective study of the effect of immersive virtual reality on the perception of pain during peripheral IV (PIV) placement. Adult patients who require PIV placement for elective surgery will be consented for intervention while in the peri-operative suites (PS). The VR intervention will consist of a headset and immersive VR software that allows the patient to engage in a virtual world during PIV placement. Subjects will be queried immediately after PIV placement using the validated graphic rating scale regarding the sensory, cognitive, and affective aspects of discomfort they experienced with PIV placement (Appendix A). They will also be asked two validated questions concerning patient satisfaction (Dexter et al 1997). A control group of patients will undergo a similar assessment with slightly different wording after receiving PIV placement without iVR.

Being tested
Virtual reality, Peripheral intravenous catheter placement
Keywords
Adult, Peripheral IV, procedural pain, procedural anxiety, virtual reality, peripheral intravenous catheter
Medical subject headings
Pain, Procedural

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual realityDevice

    Also called Samsung Gear Headset, AppliedVR software

    Healthcare virtual reality software implemented during peripheral intravenous catheter placement

  • Peripheral intravenous catheter placementProcedure or surgery

    Also called IV, PIV

    Peripheral intravenous catheters are placed in the peri-operative suites in preparation for anesthesia during surgery.

Study groups in NCT03740607
Study groupRoleWhat they receive
Virtual reality during PIV placementExperimentalRandomized consented adult subjects will participate in a six-minute healthcare virtual reality software program via Samsung Gear virtual reality headsets while receiving 18 or 20-gauge peripheral intravenous catheter placement in peri-operative suite in preparation for surgery. They will be asked to rate their pain and discomfort afterwards using a graphic rating scale. They will be asked several questions about satisfaction, in order to elicit clinical significance of this intervention. Demographic information will be collected, and baseline vital signs upon arrival to OR will be abstracted retrospectively.
Receives: Device: Virtual reality; Procedure: Peripheral intravenous catheter placement
Standard PIV placementPlacebo comparatorAdult control arm subjects will receive 18 or 20-gauge peripheral intravenous catheter placement according to current standard protocol, without virtual reality distraction .They will be asked to rate pain and discomfort afterwards using a graphic rating scale. Demographic information will be collected, and baseline vital signs upon arrival to OR will be abstracted retrospectively.
Receives: Procedure: Peripheral intravenous catheter placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Discomfort associated with peripheral IV placement

    Subject experiences will be measured using a validated graphic rating scale (GRS) which enquires about the extent to which the experience was unpleasant.

    Measured: This outcome will be measured immediately after peripheral IV placement

Secondary outcomes (9)
  1. Magnitude of pain severity

    Subjects will rate their worst pain during the IV placement on a scale of 1-10 out of 10 possible points

    Measured: This outcome will be measured immediately after peripheral IV placement

  2. Time spent thinking about pain

    Subject will describe the amount of time spent thinking about pain during IV placement, as a proportion.

    Measured: This outcome will be measured immediately after peripheral IV placement

  3. Degree to which subject felt immersed in virtual reality

    The subject will answer a question regarding the extent to which they felt they went "inside" the computer-generated world

    Measured: This outcome will be measured immediately after peripheral IV placement

  4. Nausea

    Subject will answer a question regarding extent to which nausea was experienced during IV placement

    Measured: This outcome will be measured immediately after peripheral IV placement

  5. Claustrophobia

    The subject will be asked to answer a question about the extent to which they felt claustrophobic for any reason during IV placement

    Measured: This outcome will be measured immediately after peripheral IV placement

  6. Clinical significance

    the subject will be asked if they would want to have their IV placed this way again

    Measured: This outcome will be measured immediately after peripheral IV placement

  7. Satisfaction score

    The subject will be asked if they were satisfied with IV placement

    Measured: This outcome will be measured immediately after peripheral IV placement

  8. Physiological parameters

    Baseline vital signs- continuous variables

    Measured: Initial vital signs at start of anesthesia care will be abstracted retrospectively. This reading will likely occur within an hour of the initial intervention, as start times for anesthesia cases are within an hour of initiation of peri-operative care

  9. Fun factor

    Subject will describe the extent to which they found the experience to be fun, on a scale of 1-10

    Measured: This outcome will be measured immediately after peripheral IV placement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2018
  2. Study start1 Mar 2019
  3. Primary completion1 Sep 2022 (estimated)
  4. Study completion15 Sep 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
randomized prospective cohort
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03740607
Sponsor's protocol ID
c.2017.114d
Status last verified
Aug 2021
First submitted
10 Nov 2018
Last updated
26 Aug 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Maani CV, Hoffman HG, Fowler M, Maiers AJ, Gaylord KM, Desocio PA. Combining ketamine and virtual reality pain control during severe burn wound care: one military and one civilian patient. Pain Med. 2011 Apr;12(4):673-8. doi: 10.1111/j.1526-4637.2011.01091.x. Epub 2011 Apr 11.

    PubMed 21481162
  • Maani CV, Hoffman HG, Morrow M, Maiers A, Gaylord K, McGhee LL, DeSocio PA. Virtual reality pain control during burn wound debridement of combat-related burn injuries using robot-like arm mounted VR goggles. J Trauma. 2011 Jul;71(1 Suppl):S125-30. doi: 10.1097/TA.0b013e31822192e2.

    PubMed 21795888
  • Gold JI, Kim SH, Kant AJ, Joseph MH, Rizzo AS. Effectiveness of virtual reality for pediatric pain distraction during i.v. placement. Cyberpsychol Behav. 2006 Apr;9(2):207-12. doi: 10.1089/cpb.2006.9.207.

    PubMed 16640481
  • Indovina P, Barone D, Gallo L, Chirico A, De Pietro G, Giordano A. Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures: A Comprehensive Literature Review. Clin J Pain. 2018 Sep;34(9):858-877. doi: 10.1097/AJP.0000000000000599.

    PubMed 29485536
  • Rosen LD, Whaling K, Carrier LM, Cheever NA, Rokkum J. The Media and Technology Usage and Attitudes Scale: An empirical investigation. Comput Human Behav. 2013 Nov 1;29(6):2501-2511. doi: 10.1016/j.chb.2013.06.006.

    PubMed 25722534
  • Tashjian VC, Mosadeghi S, Howard AR, Lopez M, Dupuy T, Reid M, Martinez B, Ahmed S, Dailey F, Robbins K, Rosen B, Fuller G, Danovitch I, IsHak W, Spiegel B. Virtual Reality for Management of Pain in Hospitalized Patients: Results of a Controlled Trial. JMIR Ment Health. 2017 Mar 29;4(1):e9. doi: 10.2196/mental.7387.

    PubMed 28356241
  • Hoffman HG, Richards TL, Van Oostrom T, Coda BA, Jensen MP, Blough DK, Sharar SR. The analgesic effects of opioids and immersive virtual reality distraction: evidence from subjective and functional brain imaging assessments. Anesth Analg. 2007 Dec;105(6):1776-83, table of contents. doi: 10.1213/01.ane.0000270205.45146.db.

    PubMed 18042882
  • Hoffman HG, Patterson DR, Seibel E, Soltani M, Jewett-Leahy L, Sharar SR. Virtual reality pain control during burn wound debridement in the hydrotank. Clin J Pain. 2008 May;24(4):299-304. doi: 10.1097/AJP.0b013e318164d2cc.

    PubMed 18427228
  • Dexter F, Aker J, Wright WA. Development of a measure of patient satisfaction with monitored anesthesia care: the Iowa Satisfaction with Anesthesia Scale. Anesthesiology. 1997 Oct;87(4):865-73. doi: 10.1097/00000542-199710000-00021.

    PubMed 9357889
  • Malloy KM, Milling LS. The effectiveness of virtual reality distraction for pain reduction: a systematic review. Clin Psychol Rev. 2010 Dec;30(8):1011-8. doi: 10.1016/j.cpr.2010.07.001. Epub 2010 Jul 13.

    PubMed 20691523
  • Kenney MP, Milling LS. The effectiveness of virtual reality distraction for reducing pain: a meta-analysis. Psychology of Consciousness: Theory, Research, and Practice 3(3): 199-210, 2016.

Questions about this trial

What is this clinical trial studying?

A study testing Virtual reality and Peripheral intravenous catheter placement in people with Procedural Anxiety and Procedural Pain, run by Brooke Army Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Annie L Chow, MD, MPH, MS (6093063329, chowanni@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Discomfort associated with peripheral IV placement (time frame: This outcome will be measured immediately after peripheral IV placement). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03740607, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in